Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy
Nutrients · 29.10.2025 · 17 (21) · 3401
DOI: 10.3390/nu17213401 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 29.10.2025. Verfasst von Jihang Xie und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611…. Hauptthemen laut MEDLINE: Xanthones, Liver Diseases, Antioxidants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhangyi.
Abstract (Originalsprache)
Mangiferin (MF), a natural component widely found in fruits, vegetables, and herbs, has garnered increasing attention for its potent antioxidative properties and therapeutic potential. This bioactive xanthone compound plays a crucial role in mitigating oxidative stress, which is a key factor in the pathogenesis of various diseases, including liver diseases. As a powerful natural antioxidant, MF exhibits a wide range of hepatoprotective effects, making it a promising candidate for liver disease therapy. In this review, we systematically examine the source and chemical properties, synthetic pathways, pharmacokinetic characteristics, and bioavailability enhancement strategies of MF. Furthermore, we explore its mechanisms of action in treating liver diseases, with a focus on its antioxidative properties and their role in modulating liver disease progression. Given the growing burden of liver disease and the limitations of current therapies, this review aims to promote the clinical application of MF as a therapeutic candidate, paving the way for innovative therapeutic strategies for liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- School of Ethmic Medicine, Chengdu University of Taditional Chinese Medicine, Chengdu 611137, China.
- Fujian Key Laboratory of Polymer Materials, Fujian Provincial Key Laboratory of Advanced Materials Oriented Chemical Engineering, College of Chemistry and Materials Science, Fujian Normal University, Fuzhou 350007, Chin…
- Innovation Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
ORCID-Profile: Ting Wang
Förderung
- Zhangyi
Zitieren
APA
Xie, J., Su, S., Wu, J., Yang, X., Zhang, Q., Shen, X., Zhao, L., Wang, T., Feng, N., Su, J., & Zhang, Y. (2025). Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy. Nutrients, 17(21), 3401. https://doi.org/10.3390/nu17213401
Vancouver
Xie J, Su S, Wu J, Yang X, Zhang Q, Shen X, et al. Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy. Nutrients. 2025;17(21):3401. doi:10.3390/nu17213401
BibTeX
@article{Xie2025,
author = {Xie, Jihang and Su, Sijing and Wu, Jianfa and Yang, Xing and Zhang, Qian and Shen, Xiaojiang and Zhao, Linlin and Wang, Ting and Feng, Nana and Su, Jinsong and Zhang, Yi},
title = {Unlocking Mangiferin: A Therapeutic Candidate Revolutionizing Liver Disease Therapy},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {21},
pages = {3401},
doi = {10.3390/nu17213401}
}
EUVIMED